One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-150200
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
Affiliation: Institut Català d'Oncologia, University of Barcelona, Institut d'Investigació Biomédica de Bellvitge, Central University Hospital of Asturias, Marqués de Valdecilla University Hospital, Hospital de Sant Pau, Hospital Universitario Virgen del Rocío, Hospital Universitario Virgen de las Nieves, INCLIVA Health Research Institute, University of Valencia, Hospital de Cruces, Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Josep Carreras Leukaemia Research Institute, Hospital Universitario 12 De Octubre, Hospital Son Llatzer, Paracelsus Medical University, Hospital Universitari i Politècnic La FeBrentuximab Vedotin Plus ESHAP (BRESHAP) Versus ESHAP As Salvage Strategy for Patients with Primary Refractory or Relapsed Classical Hodgkin's Lymphoma. Preliminary Results from the Breselibet Prospective Clinical Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
